Treatment outcomes of slow coagulation transscleral cyclophotocoagulation in pseudophakic patients with medically uncontrolled glaucoma
American Journal of Ophthalmology Apr 16, 2021
Khodeiry MM, Sheheitli H, Sayed MS, et al. - In this retrospective case series, researchers sought to report treatment outcomes of slow coagulation transscleral cyclophotocoagulation (TSCPC) as an initial surgical intervention in pseudophakic glaucomatous patients. Participants in the study were 74 pseudophakic patients (mean age of 82.6 ± 12.5 years and mean follow-up of 18.7 ± 9.1 months) with a diagnosis of glaucoma and no previous glaucoma surgeries. According to findings, IOP declined from 27.5 ± 9.8 mmHg preoperatively to 16.1 ± 6.3 mmHg postoperatively. Slow coagulation TSCPC has good efficiency, particularly in patients with baseline IOP > 21 mmHg, and safety profile as an initial surgical intervention in pseudophakic glaucomatous patients. There were no serious complications observed, and the majority of the complications were mild and transient.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries